REACH Behavioral Health

REACH Behavioral Health offers Spravato (esketamine) at its Westpark clinic in Cleveland, Ohio for adults with treatment-resistant depression who have not improved with traditional antidepressants and therapy. The practice reports that over 75 percent of its patients experience significant relief after just three treatments, with initial relief possible within 24 hours.

Spravato is self-administered as a nasal spray in the clinic, followed by two hours of monitoring by an onsite nurse practitioner. A typical schedule begins with two treatments weekly for four weeks, then tapers to weekly and maintenance dosing as patients improve.

The process starts with a confidential intake call and an optional free consultation with a psychiatrist. REACH provides psychiatry, therapy, and day treatment across Ohio, with Spravato covered by most insurance plans including Medicaid.